Pharmacy Report Archives - Page 13 of 150 - Becker's Hospital Review

Cone Health grows infusion volume | Intellia gene therapy trial resumes | Emory names drug safety exec | 50 best hospitals: Healthgrades | Nebraska hospital, farmers launch biotech startup

FDA lifts hold on Intellia gene therapy trial & Cone Health infusion volume up 40% January 27, 2026 1. How Cone Health is rethinking infusion services Full story 2. FDA lifts hold on Intellia's phase 3 trial for genetic nerve…

Hospitals to feds: Block Eli Lilly's 340B claims rule | Texas AG probes vaccine incentives | Drug shortages hit 20-year low | AI partnership targets pharmacy workforce growth | Pharmacists among 31K striking Kaiser workers

Vaccine updates, drug supply shifts and pharmacy expansion lead today’s news January 26, 2026 1. Texas attorney general probes alleged immunization 'incentives': 4 vaccine updates Full story 2. New drug shortages hit 20-year low: ASHP report Full story 3. What's…

UVA Health's pharmacy reboot | CVS draws antitrust scrutiny over digital pharmacy limits | 10 systems seeking pharmacy leaders | FDA pilot aims to boost US drug supply | Trump's health plan: 3 big Qs

UVA’s pharmacy expansion, CVS antitrust scrutiny + domestic drug supply efforts lead today’s news January 22, 2026 1. House committee accuses CVS of impeding pharmacy competition Full story 2. UVA Health distributed 1M prescriptions in one year after pharmacy reboot…

Pharmacy leaders look 50 years ahead | 3 drugs to watch: Optum | Pharmacists applaud Congress' PBM proposals | FDA fast-tracks Novartis drug | Mo. sues drugmakers, PBMs

Pharmacy strategy, FDA moves and drug pricing pressure headline today’s news January 21, 2026 1. Pharmacy leaders look 50 years ahead Full story 2. Pharmacy groups back PBM reforms in spending package Full story 3. 24/7/365 telepharmacy can drive financial…

Cone Health taps CPO | Drug shortages strain primary care | FDA delays 2 priority voucher reviews | Cedars-Sinai builds drug safety AI | Compounding pharmacy sues over GLP-1 access

Pharmacy leadership changes, drug shortages and regulatory delays top today’s news January 20, 2026 1. Former Geisinger pharmacy leader joins Cone Health as CPO Full story 2. FDA delays 2 drug reviews in priority voucher program Full story 3. Drug shortages…

5 ways pharmacies rebuild hospital supply chains | Express Scripts faces $10.9M Rx 'flipping' lawsuit | 10 systems hiring pharmacy leaders | Pharmacists face higher suicide risk: Study | Emojis gain ground in patient records

Hospital pharmacies adjust supply chains & Express Scripts faces $10.9M lawsuit. January 15, 2026 1. 5 ways pharmacy leaders are rebuilding supply chains after drug shortages Full story 2. Pharmacists face higher suicide risk: 4 things to know Full story…

FDA seeks GLP-1 label change | Mount Sinai rewires pharmacy ops with AI | 20 influential drug approvals in '25 | Best healthcare jobs: Where pharmacists, pharmacy techs rank | What wrecks hospital turnarounds?

FDA seeks GLP-1 label change & Mount Sinai rewires pharmacy ops. January 14, 2026 1. FDA moves to strike suicide risk warnings from 3 GLP-1s Full story 2. How Mount Sinai is rewiring pharmacy for the AI era Full story…

HHS may reconsider 340B pilot | Hospital groups to CMS: Revise drug cost survey | FDA approves 1st therapy for rare pediatric disease | U of Hawaii launches remote PharmD program | Hospitals rethink PTO

HHS reconsiders 340B pilot & hospitals press CMS on drug cost survey. January 13, 2026 1. HHS may reconsider blocked 340B rebate pilot after court ruling Full story 2. Hospital groups push CMS to revise drug cost survey Full story…

Drug approvals to watch in 2026 | FDA loosens cell, gene therapy rules | Amazon adds oral Wegovy | Pharmacists transform rural health | Flu-related pediatric hospitalizations rise

2026 drug approvals, FDA pathway shifts and rural pharmacy expansion lead today’s news January 12, 2026 1. Drug approvals to watch in 2026 Full story 2. FDA eases approval path for cell, gene therapies Full story 3. From generics to…

Geisinger's biosimilar-1st strategy | Tamiflu in shortage | 10 systems seeking pharmacy leaders | Drugmakers recalibrate pricing strategies | Jefferson Health sues PBMs, drugmakers

Geisinger's biosimilar strategy, Tamiflu in shortage & drug pricing shifts. January 8, 2026 1. Why Geisinger went biosimilar-1st across its pharmacy portfolio Full story 2. Tamiflu in shortage Full story 3. AI is helping predict med inventory risks early —…